WallStreetZenWallStreetZen

NYSE: USNA
Usana Health Sciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Usana Health Sciences earnings were $42.0M for the trailing 12 months ending Dec 28, 2024, with -33.5% growth year over year. The latest USNA earnings report on Dec 28, 2024 announced Q4 2024 earnings of $4.5M, down 58% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, USNA reported annual earnings of $42.0M, with -34.1% growth.

USNA past earnings growth

How has USNA's earnings growth performed historically?

Company
-33.53%
Industry
15.05%
Market
65.38%
USNA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
USNA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
USNA's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

USNA earnings history

Current Revenue
$854.5M
Current Earnings
$42.0M
Current Profit Margin
4.9%
USNA's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

USNA Return on Equity

Current Company
8.1%
Current Industry
9.9%
Current Market
34.1%
USNA's Return on Equity (8.1%)... subscribe to Premium to read more.
High Return on Equity Performance

USNA undefined

Current Company
6.3%
Current Industry
6.4%
USNA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when USNA announces earnings.

USNA undefined

Current Company
12.59%
Current Industry
11.9%
USNA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

USNA vs Food Stocks

TickerEBITDAEarningsY/Y EarningsEPS
USNA$98.83M$42.03M-13.10%$2.20
BGS-$85.06M-$251.25MN/A-$3.18
WEST-$7.97M-$79.95MN/A-$0.89
STKL$45.48M-$17.93MN/A-$0.15
BRCC$18.60M-$2.95MN/A-$0.04
View Top Food Stocks

Usana Health Sciences Earnings Reports & History FAQ

What were Usana Health Sciences's earnings last quarter?

On USNA's earnings call on Invalid Date, Usana Health Sciences (NYSE: USNA) reported Q4 2024 earnings per share (EPS) of $0.23, up 73.56% year over year. Total USNA earnings for the quarter were $4.45 million. In the same quarter last year, Usana Health Sciences's earnings per share (EPS) was $0.87.

If you're new to stock investing, here's how to buy Usana Health Sciences stock.

Is Usana Health Sciences profitable or losing money?

As of the last Usana Health Sciences earnings report, Usana Health Sciences is currently profitable. Usana Health Sciences's net profit (also called net income) for the twelve months ending Dec 28, 2024 was $42.03 million, a 34.11% decrease year over year.

What was USNA's earnings growth in the past year?

As of Usana Health Sciences's earnings date in Invalid Date, Usana Health Sciences's earnings has grown -33.53% year over year. This is 48.58 percentage points lower than the US Packaged Foods industry earnings growth rate of 15.05%. USNA earnings in the past year totalled $42.03 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.